INVESTMENT IN IMAGION BIOSYSTEMS (Details Narrative) - USD ($)	3 Months Ended	6 Months Ended
Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Investment	$ 2,132,000		$ 2,132,000		$ 5,505,000
(Loss) on fair value adjustment of investments	$ 973,000	$ (203,000)	$ 3,373,000	$ (203,000)
Imagion Biosystems, Inc., [Member]
Common stock acquired shares	64,099,476		64,099,476
Noncontrolling interest rate	31.00%		31.00%
Trading price per share	$ 0.033233		$ 0.033233
Investment	$ 2,130,000		$ 2,130,000
(Loss) on fair value adjustment of investments			$ 3,372,000

- Definition

This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting and losses recognized for other than temporary impairments (OTTI) of the subject investments.

+ References + Details